SCHEMBL20206272

SCHEMBL20206272

C=CC(O)Nc1ccccc1C

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ HPGD P15428 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ GAA P10253 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ POLB P06746 3/20 0.38
▸ EGFR P00533 1/20 0.37
▸ MMP1 P03956 1/20 0.37
▸ MMP2 P08253 1/20 0.37
▸ MMP9 P14780 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29067537 0.77 MAPT (0.41) NPC1RAB9AHPGDALDH1A1MAPT
SCHEMBL3624335 0.76 KMT2A (0.43) HPGDALDH1A1HTTGAATDP1
SCHEMBL2230553 0.75 NPC1 (0.48) NPC1RAB9AHPGDALDH1A1MAPT
SCHEMBL24291856 0.75 ALDH1A1 (0.41) NPC1RAB9AHPGDALDH1A1MAPT
SCHEMBL3626947 0.73 L3MBTL1 (0.43) HPGDALDH1A1GAAKDM4ETDP1
SCHEMBL646260 0.71 TDP1 (0.44) ALDH1A1GAATDP1LMNA
SCHEMBL4892420 0.71 NPC1 (0.44) NPC1RAB9AHPGDALDH1A1MAPT
SCHEMBL4790891 0.70 MEN1 (0.49) NPC1RAB9AALDH1A1MAPTGAA
SCHEMBL22584974 0.70 CA12 (0.31) —
SCHEMBL30461968 0.70 MAPT (0.50) NPC1RAB9AHPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3204382-B1 HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF MERCK PATENT GMBH (DE) 2021-12-01 — — EP disclosed
WO-2018098367-A1 INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-05-31 — — WO disclosed
Send feedback